Stockreport

Cempra: Why This Small-Cap Biotech May Soar Soon [Seeking Alpha]

CEMPRA  (CEMP) 
US:NASDAQ Investor Relations: ir.melinta.com/investor-relations
PDF Summary Cempra, Inc. (NASDAQ: CEMP ) is an American, clinical-stage biotechnology company focused on developing anti-infectives for the acute care and communal dis [Read more]